Summary
Articles with the terms "superbug", "known as gram-negative bacteria" , "so called gram-positve category" and "ultra resistant" do not give the reader much confidence in the "facts and figures" that are presented in the publication. Hospital microbiology labs, infectious disease specialists, epidemiologist and infection control groups need to design more clinical trials to determine if acquired resistance is truly more significant in nosocomial infections versus environmental bacteria with more innate resistance such as the Pseudomonas sp., Acinetobacter sp., Enterobacter sp., etc.
Analysis
The crux of the antimicrobial resistance situation is not if bacteria acquire resistance or the host acquire's innate resistant environmental bacteria, but, that the patient and doctor have more effective types of antimicrobials to use for infection control. Is overuse of antibiotics the culprit or delayed underuse or just not having enough choices in antimicrobials? Like "drill baby drill" for oil we need to "discover baby discover" for antimicrobials.
